Organization
Emeritus Research Melbourne
2 abstracts
Abstract
ASSOCIATION OF EARLY REMISSION ON CLINICAL AND PATIENT-REPORTED OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS: POST-HOC ANALYSIS OF DATA FROM THE SELECT-COMPARE STUDYOrg: AbbVie Inc., North Chicago, IL, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, Rheumatism Foundation Hospital, Heinola, National Public Health Institute, Helsinki, Finland, Centre for Immunology and Cancer Research, University of Queensland, Brisbane, Australia, Monash University School of Public Health and Preventive Medicine, Emeritus Research Melbourne, Anuja Dokras,
Abstract
BENEFIT–RISK ANALYSIS OF UPADACITINIB VERSUS ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND HIGHER OR LOWER RISK OF CARDIOVASCULAR DISEASEOrg: AbbVie Inc., North Chicago, IL, Botnar Research Centre, University of Oxford, Oxford, United Kingdom, Rheumatism Foundation Hospital, Heinola, National Public Health Institute, Helsinki, Finland, Centre for Immunology and Cancer Research, University of Queensland, Brisbane, Australia, Emeritus Research Melbourne, Monash University School of Public Health and Preventive Medicine, Organización Medica de Investigación,